The FDA has just granted NJOY LLC a marketing license for its Ace enclosed e-cigarette device and three accompanying tobacco-flavored cartridge-flavored devices. This authorization allows these products to be sold legally in the United States, but it does not mean these products are safe or "FDA-approved."
The agency also issued marketing denials (Mdos) to NJOY for a variety of other Ace products. The products must be removed or the FDA may take enforcement action, and two mint-flavored Ace Vape shells are still under FDA review.
Similarly, the FDA recently released the MDO for the MyBLu e-cigarette device and several tobacco-flavored cigarette bombs. The agency said allowing the sale of the products was "not appropriate to protect public health" because Fontem had failed to provide "sufficient evidence of design characteristics, manufacture and stability". Reason stressed that this "illustrates how vague the standard is and how arbitrary the FDA applies it."
Previous articles have reported that the FDA issued Mdos without giving evidence to support its decisions. The first rejections came in early August 2021, when the FDA announced that it would not even review 4.5 million applications from the same company, JD Nova, on the grounds that they did not include adequate environmental assessments.
At the end of the same month, the agency issued applications related to flavored e-cigarette products (55,000 from one company and 800 from another), saying they failed to provide "product-specific scientific evidence that the benefits to adult smokers will overcome the risks to youth."

